Please confirm that you would like to log out of Medscape.
If you log out, you will be required to enter your username and password the next time you visit.
Log outCancel
Joint Meeting of the American Society for Blood and Marrow Transplantation (ASBMT) and the Center for International Blood and Marrow Transplant Research (CIBMTR)
February 19 - 23, 2020; Orlando, Florida
February 19 - 23, 2020Orlando, Florida
TCT 2020Geriatric Assessment Before HSCT Supports Good OutcomesSurvival outcomes support the benefits of a geriatric assessment for patients age 70 and older with blood cancers who are candidates for hematopoietic stem cell transplants (HSCT).
Medscape Medical News, February 24, 2020
TCT 2020Caution: Higher Radiation Dose Linked to Worse NHL OutcomesAmong patients with non-Hodgkin lymphoma who underwent reduced-intensity conditioning for stem cell transplant, overall survival was lower if they received a higher dose of radiation.
Cord Blood Instead of Bone Marrow for HSCT for Blood CancersClinicians should get over their preconceptions about sourcing stem cells from cord blood for transplants in hematologic malignancies,
as it can achieve good short- and long-term outcomes, says an expert in the field.
Medscape Medical News, Feb 21, 2019
Ixazomib Shows Promise as Option for Chronic GVHDPatients with advanced chronic graft versus host disease who have failed multiple therapies may respond to ixazomib, a drug
approved for second-line multiple myeloma treatment, say US scientists.
Medscape Medical News, Feb 26, 2019
Treosulfan Better Than Busulfan in Prep for HSCTOlder and sicker patients with acute myeloid leukemia undergoing stem cell transplant may fare better if they are given a
treosulfan- rather than busulfan-based regimen, German scientists have shown.
